Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model.
about
Oncolytic virus therapy: A new era of cancer treatment at dawnTo Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic VirusesOncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapyImmunotherapy for primary brain tumors: no longer a matter of privilegeOncolytic viruses as anticancer vaccinesTreatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus.Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers.Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cellsDesigning Herpes Viruses as Oncolytics.Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases.EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMASingle agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastomaViral therapy of glioblastoma multiforme.Targeting cancer stem cells with oncolytic virusA patient-specific therapeutic approach for tumour cell population extinction and drug toxicity reduction using control systems-based dose-profile design.11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cells with Enhanced Synergistic Activity.Evolution of oncolytic viruses: novel strategies for cancer treatment.Oncolytic viruses and their application to cancer immunotherapyOncolytic viral therapy: targeting cancer stem cellsStem cell in alternative treatments for brain tumors: potential for gene delivery.Calpain-dependent clearance of the autophagy protein p62/SQSTM1 is a contributor to ΔPK oncolytic activity in melanoma.In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.In situ vaccination for the treatment of cancer.Preclinical Mouse Models for Analysis of the Therapeutic Potential of Engineered Oncolytic Herpes VirusesIn vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model.Oncolytic virus as a cancer stem cell killer: progress and challenges.Oncolytic herpes simplex virus interactions with the host immune system.M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastomaZika virus has oncolytic activity against glioblastoma stem cells.Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade.Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.Immunovirotherapy for the treatment of glioblastoma.Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.
P2860
Q26739714-1720350E-05F7-4735-BC0E-3A99B196B212Q26767212-E41A145E-B6E1-45A2-8080-3496D6A28C15Q26998111-87E7CEBA-0CB3-405E-8A33-FE52A5EA783AQ27002510-D8305867-E7D6-49FF-A2A3-2593D9E0B28EQ27025600-6E60CB85-C326-4A61-B860-F0D29B4E1340Q33894449-688E395C-8895-474B-89B6-D446B762E45BQ34408794-93052ED8-6270-4401-A748-0A8CC5BEDAE6Q35210355-B1B0E04A-D8DB-4BDB-B4C7-5A3304CB9206Q35545752-DB97E2AE-6727-4D75-BCCA-6F524A34AA7AQ36142487-C9C5D257-7F59-477B-A59E-CA603B5B90BAQ36165598-0C777EA0-B71A-4268-9628-5BF6F52ABC84Q36544212-A67DB10E-C547-4C9B-AD87-261B1655AD55Q36549443-77AF99CF-85AB-4677-A14C-2E348926DF19Q36575238-3164E8CC-CBCC-4274-8CF2-31E06E3C84BFQ37031664-7004E1D6-CF94-4E02-8909-028C6475A4A7Q37044088-F0C18DA1-7B71-484B-B8D9-883A6FC9084FQ37497227-7229C3E3-1620-4D77-9F28-7986D240A5B8Q37667771-10B95656-ACA5-4F15-8254-B7DCB07BAD43Q38159802-0AF38544-7187-46EF-8917-84FB310FEA85Q38207011-9C29BED4-A79F-48E1-952B-977B54D5A71DQ38212255-AA6FDE97-4F2C-4F24-926F-0ED696CD3ECFQ38521752-C4ED50DD-3A74-4A34-A5F4-7E867A80E5C0Q38615069-580B188E-9459-4B86-858E-397CC429FDF0Q38657642-8E5705E7-8AB4-4561-895E-C6AF2EFAC6EEQ38703318-8F5405AF-66BA-420A-8D7D-D114D9EF03AFQ38727470-C9AF618B-C7B2-4791-8D83-DA1306AF395DQ38795324-4EC478B1-C394-43D0-8690-6DCB87FB4E57Q38850871-CAFCBB4E-9E1B-4E7E-881A-772B7769462EQ38879452-52E9C9B1-D4C8-4BF3-BF07-32F57352542EQ38881477-520A89BB-74E4-4E2E-887B-E25F9CAD9D72Q38920459-381FD3DA-D1E5-4C95-A797-2553A42A00CEQ39932965-D9884C23-6037-4D3A-9C5C-C6B583C484EAQ40037821-028477D8-E277-475C-9BAF-DD4B6A358925Q40082476-3C22B95F-5779-4A75-B8DE-D4B30DCFC698Q40122051-D8B44FAE-5E59-468A-B56E-3FB309FD817AQ40178043-B75BF984-40EC-4E8E-BCBE-A1EBC9AB92A3Q40867510-5FBC3F27-5309-42E9-B2E6-DAA6A257F1E8Q41919532-A00DD886-FBF8-485B-BBA6-3EEF37D3226AQ41966303-C3A6C920-1C07-42EA-96B0-2B2065BA6AA3Q42218017-05F335D2-C7FA-405E-A3ED-5DF327B6C87E
P2860
Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multifaceted oncolytic virus t ...... petent cancer stem cell model.
@en
Multifaceted oncolytic virus t ...... petent cancer stem cell model.
@nl
type
label
Multifaceted oncolytic virus t ...... petent cancer stem cell model.
@en
Multifaceted oncolytic virus t ...... petent cancer stem cell model.
@nl
prefLabel
Multifaceted oncolytic virus t ...... petent cancer stem cell model.
@en
Multifaceted oncolytic virus t ...... petent cancer stem cell model.
@nl
P2093
P2860
P50
P356
P1476
Multifaceted oncolytic virus t ...... petent cancer stem cell model.
@en
P2093
Deva S Jeyaretna
Hiroaki Wakimoto
Jianfang Ning
Peter E Fecci
Tooba A Cheema
P2860
P304
12006-12011
P356
10.1073/PNAS.1307935110
P407
P577
2013-06-10T00:00:00Z